OPT
Click for more information
1.47% 34.5¢ opthea limited

Ann: Opthea Completes Enrollment in First Trial of Sozinibercept, page-9

  1. LongMemory
    37 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    15/02/24
    10:47
    Post #: 72418641
    Remember Opthea has received FDA fast track designation - so things will move very quickly post top line data read out at 52 weeks.
    OPT Price at posting: 59.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AWJ Auric jumps 10% on maiden cash sales in Q3CY24 and firm guidance
right-arrow Created with Sketch.
NEWS The Big Deal: Free-to-air TV swings the axe, but will it be enough as enormous sports deal bills loom?
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
34.5¢ 		Change
0.005(1.47%) 		Mkt cap ! $371.0M
Open High Low Value Volume
34.0¢ 35.0¢ 33.5¢ $986.8K 2.875M

Buyers (Bids)

No. Vol. Price($)
2 55705 34.5¢
 

Sellers (Offers)

Price($) Vol. No.
35.0¢ 29727 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.